The $150M offering provides substantial cash runway for Mint™ commercialization but creates significant near-term dilution (~17-22%). Watch for the closing on Sept 17 and any subsequent updates on Mint™ launch timing and manufacturing scale-up. The stock may face continued pressure from the overhang of the overallotment option and potential secondary sales.
Price Chart
Executive Summary
Beta Bionics priced a $150M underwritten public offering of 7.65M shares at $17.25/share plus pre-funded warrants, representing ~27% dilution based on the pre-offering share count. The proceeds will fund commercialization of the Mint™ system, manufacturing expansion, and R&D. The offering is expected to close September 17, 2026.
Key Financial Metrics
Key Facts
- Priced 7,652,175 shares of common stock at $17.25 per share
- Plus pre-funded warrants for 1,043,484 shares at $17.2499 each
- Gross proceeds of $150.0 million
- Underwriters have 30-day option for up to 1,304,348 additional shares
- Offering expected to close on or about September 17, 2026
- Net proceeds for general corporate purposes including Mint™ commercialization, manufacturing expansion, R&D, and potential strategic opportunities
Financial Impact
$150M gross proceeds; dilution of ~27% based on pre-offering share count (assuming ~28.3M shares outstanding pre-offering, estimated from market cap of $753M at $17.25/share = ~43.7M shares pre-offering, so 7.65M shares = ~17.5% dilution; plus warrants and overallotment option could increase dilution to ~22%)
Risk Factors
- Dilution of ~17-22% from new shares and warrants
- Potential additional dilution from underwriters' 30-day overallotment option (up to 1.3M more shares)
- Execution risk in commercializing Mint™ and expanding manufacturing
- Forward-looking statements subject to market conditions and closing conditions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3362820 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 19d ago | SC 13G | $18.08 | awaiting T+20 | — | $20.51 (+13.44%) |
Sep 23, 2026 4w ago | Insider Cluster | $21.76 $19.34 | ▲ +11.12% | ▲ +10.70% | $20.51 (+5.74%) |
Sep 18, 2026 5w ago | Insider Cluster | $22.04 $16.84 | ▲ +23.59% | ▲ +22.69% | $20.51 (+6.94%) |
Sep 17, 2026 5w ago | Press Release | $21.89 $16.35 | ▼ −25.31% | ▼ −25.51% | $20.51 (−6.30%) |
Sep 17, 2026 5w ago | Insider Cluster | $21.89 $16.35 | ▼ −25.31% | ▼ −25.51% | $20.51 (−6.30%) |
Sep 15, 2026 5w ago | Press Release | $22.18 $16.87 | ▲ +23.94% | ▲ +26.00% | $20.51 (+7.53%) |
Sep 15, 2026 5w ago | 8-K | $22.18 $16.87 | ▼ −23.94% | ▼ −26.00% | $20.51 (−7.53%) |
Sep 15, 2026 5w ago | Press Release | $22.18 $16.87 | ▲ +23.94% | ▲ +26.00% | $20.51 (+7.53%) |
Sep 14, 2026 6w ago | Press Release | $16.73 $17.86 | ▲ +6.75% | ▲ +4.49% | $20.51 (+22.59%) |
Sep 10, 2026 6w ago | Insider Cluster | $16.57 $17.63 | ▼ −6.40% | ▼ −4.53% | $20.51 (−23.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers